Theodore R. Samuels II

This profile gathers the share dealings of Theodore R. Samuels II across 5 companies, led by Centene Corp, PERRIGO Co plc and Bristol Myers Squibb Co. Over a trading history stretching from 27 February 2017 to 30 September 2026, the count stands at 47 filings.

The open-market record is one-sided, with 13 purchases worth €3.8M and not one sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 25 share grants and 7 option exercises.

A typical purchase (the median) is worth €214k. Clusters matter here: 4 out of 13 purchases overlapped with buying by a colleague within 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 3 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 67% of cases, with a median move of +10.2%. Past outcomes like these are no guarantee of what comes next.

On 30 September 2026 came the latest disclosure, a share grant in Centene Corp. The most recent open-market purchase was published on 29 July 2025, 452 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.